CompletedNot Applicable

Turkish Validity and Reliability Study of Diabetes-Specific Nutrition Knowledge Questionnaire in Adolescents With Type 1 Diabetes

Turkey (Türkiye)150 participantsStarted 2023-09-01

Plain-language summary

It is aimed to contribute to the Turkish Nutrition Sciences literature and shed light on the studies of future generations by establishing the Turkish validity and reliability of this scale, which was developed for adolescents with type 1 diabetes and their parents and was designed to evaluate general and diabetes-specific nutrition knowledge. Hypotheses: * H1: Diabetes-Specific Nutrition Information Scale for Adolescents with Type 1 Diabetes is a reliable tool for the Turkish population. * H2: Diabetes-Specific Nutrition Information Scale for Adolescents with Type 1 Diabetes is a valid tool for the Turkish society. * H3: Individuals with higher scores on the Diabetes-Specific Nutrition Information Scale in Adolescents with Type 1 Diabetes have better metabolic control. * H4: Diet quality of individuals with higher scores on the Diabetes-Specific Nutrition Information Scale for Adolescents with Type 1 Diabetes is better.

Who can participate

Age range

9 Years – 18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * duration of T1D of at least one year, * regular follow-up of at least 1 year, * no major medical problems (celiac disease, cystic fibrosis, psychiatric disorders, and communication difficulties) * the insulin requirement was \> 0.5 IU/kg/day Exclusion Criteria: * type 1 diabetes duration less than 1 year * no regular follow-up of at least 1 year * have major medical problems (celiac disease, cystic fibrosis, psychiatric disorders, and communication difficulties) the requirement was \<0.5 IU/kg/day

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Nutritional Knowledge Score

Timeframe: 3 months

Trial details

NCT IDNCT07232381

SponsorYasemin Atik Altinok

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-03-30

View on ClinicalTrials.gov More Type 1 Diabetes trials